CANY
AVIR icon

Caxton Associates (New York)’s Atea Pharmaceuticals AVIR Stock Holding History

Caxton Associates (New York)’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,998
Closed -$56.9K – 496
2023
Q1 		$56.9K Buy
+16,998
New +$56.9K 0.01% 469